Pharmaceutical Executive
March 16, 2015
Columns
35
3
Congress, Obama offer strategies to reduce regulatory roadblocks to new breakthroughs.
March 11, 2015
From the Editor
35
3
Pharma jumps on board personal genomics train-at least for test drive-but will journey ultimately help transform treatment or stall out as just another fad?
March 11, 2015
Features
35
3
Pharm Exec profiles patient DNA partnering advocate 23andMe, which recently struck data deals with a pair of big Pharmas, thrusting the debate over personal genomics and patient treatment back into high gear.
March 08, 2015
Features
35
3
A new PwC survey reveals a strong need to fully embrace alternative commercial methods-not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.
March 04, 2015
Columns
35
3
The cholesterol-fighting market is back with a vengeance; plenty of complications in store
March 01, 2015
Columns
35
3
New EU group could ultimately end up handcuffing much-needed efforts to modernize drug authorization.
March 01, 2015
Columns
35
3
How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality.